top of page


News
Categories
Sign up
Featured Posts


Archive


- Nov 23, 2022
Alpha Tau Medical Announces Third Quarter 2022 Financial Results and Provides Corporate Update
JERUSALEM, November 22, 2022 - Alpha Tau Medical Ltd. (Nasdaq: DRTS and DRTSW), ("Alpha Tau" or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, reported third quarter 2022 financial results and provided a corporate update. "Alpha Tau remained active in the third quarter, as we continued preparations for our upcoming U.S. pivotal study in recurrent cutaneous squamous cell carcinoma and laid the groundwork for exploration of our Alpha


- Nov 10, 2022
Alpha Tau to Present at Upcoming November Investor Conferences
JERUSALEM, November 9, 2022 -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau", or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced the Company will present in person at the following investor conferences in November: Event: Jefferies London Healthcare Conference Date & Time: Wednesday, November 16, 2022 at 4:25pm GMT Location: London, UK Event: Piper Sandler 34th Annual Healthcare Conference Date &
bottom of page